Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Market Cap	25.00M +1.0%
Revenue (ttm)	11.04K
Net Income	-3.13M
EPS	-0.02
Shares Out	178.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,716
Average Volume	104,847
Open	0.1400
Previous Close	0.1450
Day's Range	0.1400 - 0.1400
52-Week Range	0.1250 - 0.3600
Beta	0.05
RSI	36.65
Earnings Date	Mar 27, 2026

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Brent Willis
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VM